Global CRISPR Technology Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The CRISPR Technology Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The crispr technology market has experienced substantial expansion in recent years. Its value is anticipated to rise from $2.05 billion in 2024 to $2.53 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 23.4%. This historical growth can be linked to an uptick in funding and elevated pharmaceutical R&D expenditure.

The crispr technology market size is projected to see substantial growth over the next few years. It is set to expand to $5.71 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 22.6%. This growth during the forecast period can be attributed to an escalating demand for gene therapeutics, continuous technological advancements in the realm of genome editing, an increasing requirement for drug discovery, a heightened demand for CRISPR in diagnostics, a growing need for CRISPR technologies in agriculture applications, and a rising adoption of CRISPR technologies. Major trends expected in the forecast period include the development of innovative next-generation technology, the creation of improved CRISPR technologies for superior outcomes in new drug developments, the utilization of AI to boost the efficiency and accuracy of gene editing with CRISPR, investment in novel approaches such as IDMseq to increase accuracy, and the formation of collaborations with various companies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4018&type=smp

What Are The Main Drivers Boosting The CRISPR Technology Industry’s Expansion?

The market is anticipated to experience growth during this period, primarily driven by the application of CRISPR technology as a diagnostic tool. Notably, the Sherlock CRISPR SARS-CoV-2 kit stands as the inaugural diagnostic kit utilizing CRISPR technology specifically for infectious diseases, particularly those stemming from COVID-19. In February 2021, the FDA granted emergency use authorization for Sherlock BioSciences Inc.’s Sherlock CRISPR SARS-CoV-2 kit, a diagnostic test employing CRISPR-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) technology. This particular test is designed to precisely identify RNA or DNA sequences of the SARS-CoV-2 virus present in various samples, including nasal swabs taken from the upper respiratory tract and lung fluid obtained from bronchoalveolar lavage specimens. Characterized by high specificity and sensitivity, this diagnostic kit effectively avoids producing false negative or positive outcomes. Consequently, a broader application of CRISPR technology in diagnosing infectious diseases is expected to fuel the demand for related CRISPR products and services.

What Are The Key Segments In The CRISPR Technology Market?

The crispr technologymarket covered in this report is segmented –

1) By Product Type: Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products

2) By Application: Biomedical, Agriculture, Diagnostics, Other Applications

3) By End-User: Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs)

Subsegments:

1) By Design Tools: CRISPR Design Software; sgRNA Design Tools; Bioinformatics Platforms

2) By Plasmid and Vector: Plasmid Vectors; Viral Vectors; Bacterial Vectors

3) By Cas9 and gRNA: Cas9 Proteins; Guide RNA (gRNA) Products; Cas9 Complexes

4) By Delivery System Products: Electroporation Systems; Lipid-Based Delivery Systems; Viral Delivery Systems; Nanoparticle-Based Delivery Systems

What Are The Latest Industry Trends Transforming The CRISPR Technology Market?

Major entities active in the CRISPR technology market are employing a strategic partnership approach to offer remedies for sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). Strategic partnerships involve a process where businesses capitalize on each other’s capabilities and resources to achieve mutual gains and accomplishments. For example, in November 2023, Vertex, a UK-based call center company, formed a partnership with CRISPR Therapeutics., a Switzerland-based biotechnology company. Through this alliance, they intend to devise novel solutions and introduced CRISPR/Cas9 Gene-Edited Therapy, CASGEVYTM. This CASGEVY (exagamglogene autotemcel) employs CRISPR/Cas9 technology to modify genes in hematopoietic stem cells, thereby enabling the generation of functional hemoglobin. This can considerably diminish or eliminate painful vaso-occlusive crises related to sickle cell disease and lessen the necessity for blood transfusions in individuals with transfusion-dependent beta-thalassemia.

Who Are The Major Companies Operating In The CRISPR Technology Market?

Major companies operating in the CRISPR technology market include Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd, Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Horizon Discovery Group, Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

Which Region Currently Holds The Largest Share Of The CRISPR Technology Market?

North America was the largest region in the CRISPR technology market in 2024. Western Europe was the second largest region in the global CRISPR technology market. The regions covered in the CRISPR technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The CRISPR Technology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=4018&type=smp

Browse Through More Reports Similar to the Global CRISPR Technology Market 2025, By The Business Research Company

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

Bacterial And Plasmid Vector Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795